PFE did have a PI ready to go for SARS back in 2003. Are we sure this isn't a repurposing of that drug?
EDIT: even if this is a novel drug they could have easily revived the discovery platform and found another in their library, or tweaked the 2003 drug for current virus. i.e. they still had a head start over someone starting totally from scratch
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.